These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7102704)

  • 1. Metabolic fate of radioactive acyclovir in humans.
    de Miranda P; Good SS; Krasny HC; Connor JD; Laskin OL; Lietman PS
    Am J Med; 1982 Jul; 73(1A):215-20. PubMed ID: 7102704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of intravenous radioactive acyclovir.
    de Miranda P; Good SS; Laskin OL; Krasny HC; Connor JD; Lietman PS
    Clin Pharmacol Ther; 1981 Nov; 30(5):662-72. PubMed ID: 7297024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic disposition of acyclovir in the guinea pig, rabbit, and monkey.
    Good SS; de Miranda P
    Am J Med; 1982 Jul; 73(1A):91-5. PubMed ID: 7102713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acyclovir kinetics after intravenous infusion.
    de Miranda P; Whitley RJ; Blum MR; Keeney RE; Barton N; Cocchetto DM; Good S; Hemstreet GP; Kirk LE; Page DA; Elion GB
    Clin Pharmacol Ther; 1979 Dec; 26(6):718-28. PubMed ID: 227639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Species differences in the disposition of acyclovir.
    de Miranda P; Krasny HC; Page DA; Elion GB
    Am J Med; 1982 Jul; 73(1A):31-5. PubMed ID: 7102710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The disposition of acyclovir in different species.
    de Miranda P; Krasny HC; Page DA; Elion GB
    J Pharmacol Exp Ther; 1981 Nov; 219(2):309-15. PubMed ID: 7288622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acyclovir kinetics in end-stage renal disease.
    Laskin OL; Longstreth JA; Whelton A; Rocco L; Lietman PS; Krasny HC; Keeney RE
    Clin Pharmacol Ther; 1982 May; 31(5):594-601. PubMed ID: 7075109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of acyclovir pharmacokinetic disposition in adults and children.
    Blum MR; Liao SH; de Miranda P
    Am J Med; 1982 Jul; 73(1A):186-92. PubMed ID: 7048911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and tolerance of acyclovir, a new anti-herpesvirus agent, in humans.
    Laskin OL; Longstreth JA; Saral R; de Miranda P; Keeney R; Lietman PS
    Antimicrob Agents Chemother; 1982 Mar; 21(3):393-8. PubMed ID: 7103443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of hemodialysis on acyclovir pharmacokinetics in patients with chronic renal failure.
    Krasny HC; Liao SH; de Miranda P; Laskin OL; Whelton A; Lietman PS
    Am J Med; 1982 Jul; 73(1A):202-4. PubMed ID: 7102703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acyclovir clinical pharmacology. An overview.
    Lietman PS
    Am J Med; 1982 Jul; 73(1A):193-6. PubMed ID: 7048912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of acyclovir and its metabolite 9-carboxymethoxymethylguanine in serum and urine using solid-phase extraction and high-performance liquid chromatography.
    Svensson JO; Barkholt L; Säwe J
    J Chromatogr B Biomed Sci Appl; 1997 Mar; 690(1-2):363-6. PubMed ID: 9106067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and bioavailability of acyclovir in the dog.
    Krasny HC; de Miranda P; Blum MR; Elion GB
    J Pharmacol Exp Ther; 1981 Feb; 216(2):281-8. PubMed ID: 7463350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals.
    Whitley RJ; Blum MR; Barton N; de Miranda P
    Am J Med; 1982 Jul; 73(1A):165-71. PubMed ID: 7102700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simple high-performance liquid chromatographic method for the analysis of 9-(2-hydroxyethoxymethyl)guanine (acyclovir) in human plasma and urine.
    Land G; Bye A
    J Chromatogr; 1981 Jun; 224(1):51-8. PubMed ID: 7263820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of renal failure on the pharmacokinetics of acyclovir.
    Laskin OL; Longstreth JA; Whelton A; Krasny HC; Keeney RE; Rocco L; Lietman PS
    Am J Med; 1982 Jul; 73(1A):197-201. PubMed ID: 7102702
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of probenecid on the pharmacokinetics and elimination of acyclovir in humans.
    Laskin OL; de Miranda P; King DH; Page DA; Longstreth JA; Rocco L; Lietman PS
    Antimicrob Agents Chemother; 1982 May; 21(5):804-7. PubMed ID: 7103460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose pharmacokinetics of acyclovir.
    Spector SA; Connor JD; Hintz M; Quinn RP; Blum MR; Keeney RE
    Antimicrob Agents Chemother; 1981 Apr; 19(4):608-12. PubMed ID: 7247383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal acyclovir pharmacokinetics in patients with herpes virus infections.
    Hintz M; Connor JD; Spector SA; Blum MR; Keeney RE; Yeager AS
    Am J Med; 1982 Jul; 73(1A):210-4. PubMed ID: 6285713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo responses of cytomegalovirus to acyclovir.
    Plotkin SA; Starr SE; Bryan CK
    Am J Med; 1982 Jul; 73(1A):257-61. PubMed ID: 6285717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.